These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 17159192)

  • 41. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
    Arana-Yi C; Block AW; Sait SN; Ford LA; Barcos M; Baer MR
    Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
    Hake CR; Graubert TA; Fenske TS
    Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant myeloid transformation in congenital forms of neutropenia.
    Freedman MH; Alter BP
    Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
    Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute myelogenous leukemia and myelodysplasia secondary to breast cancer treatment: case studies and literature review.
    Cole M; Strair R
    Am J Med Sci; 2010 Jan; 339(1):36-40. PubMed ID: 19996729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
    Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
    Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute myeloid leukemia in the elderly:--159 Nagoya case studies--Nagoya Cooperative Study Group for Elderly Leukemia.
    Nagura E; Minami S; Nagata K; Morishita Y; Takeyama H; Sao H; Suzuki H; Naoe T; Yokomaku S; Mizuno H; Murase T; Hirabayashi N; Takeo T; Tanimoto M; Kawashima K; Saito H
    Nagoya J Med Sci; 1999 Nov; 62(3-4):135-44. PubMed ID: 10689875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
    Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
    Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
    Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
    Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim.
    Covert WM; Murillo JR; Cox JE
    J Oncol Pharm Pract; 2011 Dec; 17(4):366-71. PubMed ID: 20876080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased breast cancer risk after radiotherapy for acne among women with skin cancer.
    El-Gamal H; Bennett RG
    J Am Acad Dermatol; 2006 Dec; 55(6):981-9. PubMed ID: 17097395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
    Waterman J; Rybicki L; Bolwell B; Copelan E; Pohlman B; Sweetenham J; Dean R; Sobecks R; Andresen S; Kalaycio M
    Bone Marrow Transplant; 2012 Apr; 47(4):488-93. PubMed ID: 21572461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
    Choi SW; Boxer LA; Pulsipher MA; Roulston D; Hutchinson RJ; Yanik GA; Cooke KR; Ferrara JL; Levine JE
    Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
    Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
    J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
    Martinez V; Mir O; Dômont J; Bouscary D; Goldwasser F
    Anticancer Drugs; 2007 Feb; 18(2):233-5. PubMed ID: 17159610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
    Yamauchi T; Negoro E; Arai H; Ikegaya S; Takagi K; Takemura H; Inai K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Anticancer Res; 2007; 27(4C):2635-9. PubMed ID: 17695426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.